The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 10 2020
Historique:
received: 21 01 2019
accepted: 26 09 2020
entrez: 16 10 2020
pubmed: 17 10 2020
medline: 11 3 2021
Statut: epublish

Résumé

The human cathelicidin LL-37 serves a critical role in the innate immune system defending bacterial infections. LL-37 can interact with molecules of the cell wall and perforate cytoplasmic membranes resulting in bacterial cell death. To test the interactions of LL-37 and bacterial cell wall components we crystallized LL-37 in the presence of detergents and obtained the structure of a narrow tetrameric channel with a strongly charged core. The formation of a tetramer was further studied by cross-linking in the presence of detergents and lipids. Using planar lipid membranes a small but defined conductivity of this channel could be demonstrated. Molecular dynamic simulations underline the stability of this channel in membranes and demonstrate pathways for the passage of water molecules. Time lapse studies of E. coli cells treated with LL-37 show membrane discontinuities in the outer membrane followed by cell wall damage and cell death. Collectively, our results open a venue to the understanding of a novel AMP killing mechanism and allows the rational design of LL-37 derivatives with enhanced bactericidal activity.

Identifiants

pubmed: 33060695
doi: 10.1038/s41598-020-74401-5
pii: 10.1038/s41598-020-74401-5
pmc: PMC7562864
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antimicrobial Cationic Peptides 0
Biopolymers 0
Cathelicidins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17356

Références

Biophys J. 1999 Apr;76(4):1757-69
pubmed: 10096876
Trends Biotechnol. 2011 Sep;29(9):464-72
pubmed: 21680034
Biophys J. 2002 Nov;83(5):2393-407
pubmed: 12414676
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Biophys J. 2011 Jan 19;100(2):450-8
pubmed: 21244841
Int J Mol Sci. 2018 Apr 13;19(4):
pubmed: 29652823
Biochemistry. 1996 May 21;35(20):6225-32
pubmed: 8639562
Science. 2017 Feb 24;355(6327):831-833
pubmed: 28232575
Antimicrob Agents Chemother. 2013 Feb;57(2):1082-5
pubmed: 23254419
J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
Annu Rev Biochem. 1997;66:199-232
pubmed: 9242906
PLoS Pathog. 2012;8(6):e1002744
pubmed: 22685403
Antimicrob Agents Chemother. 1998 Sep;42(9):2206-14
pubmed: 9736536
Biotechnol Lett. 2008 May;30(5):813-8
pubmed: 18175069
Biophys J. 2016 Sep 6;111(5):989-98
pubmed: 27602726
J Invest Dermatol. 2010 May;130(5):1297-306
pubmed: 20090765
Nat Struct Mol Biol. 2015 Jun;22(6):470-5
pubmed: 25984971
J Immunol. 2002 Oct 1;169(7):3883-91
pubmed: 12244186
Nat Biotechnol. 2013 May;31(5):379-82
pubmed: 23657384
Curr Pharm Des. 2009;15(21):2377-92
pubmed: 19601838
Biochim Biophys Acta. 2006 Sep;1758(9):1529-39
pubmed: 16928357
Biochim Biophys Acta. 2002 Oct 11;1565(2):308-17
pubmed: 12409203
Biochim Biophys Acta. 2008 Apr;1778(4):983-96
pubmed: 18166145
Mol Syst Biol. 2006;2:2006.0008
pubmed: 16738554
Infect Immun. 1999 Dec;67(12):6445-53
pubmed: 10569762
Clin Microbiol Rev. 2006 Jul;19(3):491-511
pubmed: 16847082
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
pubmed: 9895674
J Chem Theory Comput. 2016 Jan 12;12(1):405-13
pubmed: 26631602
J Clin Microbiol. 2014 Jun;52(6):2172-4
pubmed: 24648548
Angew Chem Int Ed Engl. 2020 Jul 27;59(31):12837-12841
pubmed: 31999880
Sci Rep. 2016 Sep 14;6:32948
pubmed: 27624595
Nat Med. 2004 Dec;10(12 Suppl):S122-9
pubmed: 15577930
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):1017-1026
pubmed: 30598442
J Am Chem Soc. 2016 May 4;138(17):5706-13
pubmed: 27064294
J Supramol Struct. 1974;2(5-6):538-57
pubmed: 4461846
Biophys J. 1989 Nov;56(5):1017-21
pubmed: 2481510
Nat Rev Microbiol. 2006 Jul;4(7):529-36
pubmed: 16778838
Cell Chem Biol. 2018 May 17;25(5):530-539.e7
pubmed: 29526712
Expert Opin Ther Targets. 2007 Apr;11(4):557-65
pubmed: 17373884
Sci Rep. 2017 Nov 13;7(1):15371
pubmed: 29133814
Sci Rep. 2016 Nov 30;6:38184
pubmed: 27901075
Small. 2012 Jun 11;8(11):1701-9
pubmed: 22434668
Antimicrob Agents Chemother. 2012 Feb;56(2):838-44
pubmed: 22123698
Biochemistry. 1996 Oct 29;35(43):13723-8
pubmed: 8901513
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):133-44
pubmed: 20124693
J Biol Chem. 1982 Jun 10;257(11):6016-22
pubmed: 7076662
Biochemistry. 1999 Oct 12;38(41):13643-53
pubmed: 10521271
Biophys J. 2008 Sep 15;95(6):2636-46
pubmed: 18515396
FEBS Lett. 1995 Aug 14;370(1-2):46-52
pubmed: 7649303
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Angew Chem Int Ed Engl. 2014 Nov 3;53(45):12236-9
pubmed: 25220491
J Chromatogr B Biomed Sci Appl. 2001 Jul 15;758(2):265-75
pubmed: 11486836
Nat Rev Mol Cell Biol. 2018 Dec;19(12):755-773
pubmed: 30237470
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Methods Enzymol. 2003;374:300-21
pubmed: 14696379
Biochemistry. 2008 Mar 18;47(11):3525-33
pubmed: 18293934
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4586-91
pubmed: 23426625
Nat Rev Drug Discov. 2011 Dec 16;11(1):37-51
pubmed: 22173434
J Am Chem Soc. 2013 Oct 23;135(42):15738-15741
pubmed: 24102563
Nat Rev Microbiol. 2005 Mar;3(3):238-50
pubmed: 15703760
Pharmaceuticals (Basel). 2016 Sep 20;9(3):
pubmed: 27657092
J Mol Neurosci. 2009 Mar;37(3):201-11
pubmed: 18622586
Langmuir. 2014 Sep 2;30(34):10374-83
pubmed: 25105913
Blood. 2001 Jun 15;97(12):3951-9
pubmed: 11389039
J Biol Chem. 2008 Nov 21;283(47):32637-43
pubmed: 18818205
Front Chem. 2017 Nov 07;5:86
pubmed: 29164103
Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21223-7
pubmed: 23236158
Biophys J. 2005 Feb;88(2):1091-103
pubmed: 15556990
Sci Rep. 2019 Mar 18;9(1):4780
pubmed: 30886247
Sci Rep. 2014 Mar 12;4:4293
pubmed: 24618744
Biochemistry. 1996 Sep 3;35(35):11361-8
pubmed: 8784191
Nat Commun. 2018 Aug 29;9(1):3512
pubmed: 30158633
Biol Chem. 2012 Jul;393(7):641-6
pubmed: 22944668
Proteomics. 2016 Apr;16(8):1225-37
pubmed: 26648572
J Immunol Methods. 1988 Nov 10;114(1-2):197-205
pubmed: 3263442
J Phys Chem B. 2010 Jun 17;114(23):7830-43
pubmed: 20496934
Front Cell Infect Microbiol. 2016 Dec 27;6:194
pubmed: 28083516
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):E77-81
pubmed: 21464330
Nat Prod Rep. 2009 Dec;26(12):1572-84
pubmed: 19936387
Structure. 2000 Sep 15;8(9):981-92
pubmed: 10986465
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273
pubmed: 23341755
Integr Comp Biol. 2003 Apr;43(2):300-4
pubmed: 21680437
Oncotarget. 2015 Jul 10;6(19):16826-7
pubmed: 26219555
ACS Chem Biol. 2017 Jan 20;12(1):52-56
pubmed: 27935673
Nat Struct Mol Biol. 2015 Jun;22(6):466-9
pubmed: 25984972
Nature. 2002 Jan 24;415(6870):389-95
pubmed: 11807545
Antimicrob Agents Chemother. 2009 Jun;53(6):2499-509
pubmed: 19364862
Future Microbiol. 2013 Jul;8(7):817-9
pubmed: 23841626
Cell Immunol. 2012 Nov;280(1):22-35
pubmed: 23246832
Biochemistry. 2008 May 20;47(20):5565-72
pubmed: 18439024
Biochemistry. 2003 Oct 28;42(42):12251-9
pubmed: 14567687
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9541-6
pubmed: 9689116
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28167546
PLoS One. 2010 Mar 03;5(3):e9505
pubmed: 20209079
ACS Chem Biol. 2010 Oct 15;5(10):905-17
pubmed: 20698568

Auteurs

Enea Sancho-Vaello (E)

Unidad de Biofisica, Centro Mixto Consejo Superior de Investigaciones Cientificas-Universidad del País Vasco/Euskal Herriko Unibertsitatea (CSIC, UPV/EHU), Barrio Sarriena s/n, Leioa, Bizkaia, Spain.
Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK.

David Gil-Carton (D)

Structural Biology Unit, CIC bioGUNE, Parque Tecnológico de Bizkaia Edificio 800, 48160, Derio, Spain.

Patrice François (P)

Genomic Research Laboratory, Department of Medical Specialities, Geneva University Hospitals, University of Geneva, Genève, Switzerland.

Eve-Julie Bonetti (EJ)

Genomic Research Laboratory, Department of Medical Specialities, Geneva University Hospitals, University of Geneva, Genève, Switzerland.

Mohamed Kreir (M)

Nanion Technologies GmbH, Gabrielenstraße 9, 80636, Munich, Germany.
Janssen Pharmaceutica NV, Janssen R&D, Nonclinical Safety, Beerse, Belgium.

Karunakar Reddy Pothula (KR)

Department of Physics and Earth Sciences, Jacobs University Bremen, Campus Ring 1, 28759, Bremen, Germany.

Ulrich Kleinekathöfer (U)

Department of Physics and Earth Sciences, Jacobs University Bremen, Campus Ring 1, 28759, Bremen, Germany.

Kornelius Zeth (K)

Department of Science and Environment, Roskilde University, Universitetsvej 1, 4000, Roskilde, Denmark. kzeth@ruc.dk.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Classifications MeSH